Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Spontaneous rhabdomyosarcomas in <i>Dmd</i><sup><i>mdx</i></sup> rats.

Veterinary pathology·2026
Same author

Delivering the future of immunotherapy: A state-of-the-art review of gene editing in immune cells with lipid nanoparticles.

Materials today. Bio·2026
Same author

Post-mortem fundus photographs in sudden unexpected death in infancy: An overview of the typical findings.

Child abuse & neglect·2026
Same author

Omics in hereditary optic neuropathies: A systematic review of clinical studies with an integrated point of view.

Survey of ophthalmology·2026
Same author

Predictive factors for injection interval extension after switching to faricimab in neovascular AMD: The FAR WEST multicentre study.

Acta ophthalmologica·2026
Same author

Evolution and emergence of the integrase inhibitor 231 insertion resistance mutation in an HIV-2 strain isolated in central Portugal.

Virus genes·2026

相关实验视频

Updated: Jul 4, 2025

Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models
06:16

Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models

Published on: March 16, 2022

2.9K

曼诺糖结合的AAV2:第二代AAV载体,用于提高视网膜基因治疗效率.

Mathieu Mével1, Virginie Pichard1, Mohammed Bouzelha1

  • 1Nantes Université, CHU de Nantes, INSERM UMR 1089, TaRGeT-Translational Research in Gene Therapy Laboratory, 44200 Nantes, France.

Molecular therapy. Methods & clinical development
|February 8, 2024
PubMed
概括

新的腺相关病毒 (AAV) 载体增强了对视网膜的基因传递. 用曼诺连接体修改AAV体提高了转导效率,为治疗遗传性视网膜疾病提供了有前途的方法.

关键词:
腺相关病毒的病毒.生物结合生物结合化学 化学 化学 化学基因治疗的基因疗法视网膜 视网膜 视网膜 是一个

更多相关视频

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

21.3K
Production and Titering of Recombinant Adeno-associated Viral Vectors
08:35

Production and Titering of Recombinant Adeno-associated Viral Vectors

Published on: November 27, 2011

61.7K

相关实验视频

Last Updated: Jul 4, 2025

Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models
06:16

Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models

Published on: March 16, 2022

2.9K
Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

21.3K
Production and Titering of Recombinant Adeno-associated Viral Vectors
08:35

Production and Titering of Recombinant Adeno-associated Viral Vectors

Published on: November 27, 2011

61.7K

科学领域:

  • 眼科医生 眼科 眼科
  • 基因治疗 基因治疗
  • 分子生物学分子生物学

背景情况:

  • 遗传性视网膜疾病会导致无法治疗的失明.
  • 基因相关病毒 (AAV) 载体对体内视网膜基因治疗具有前景.
  • 当前的AAV载体可以在眼部基因治疗试验中引起剂量相关的炎症反应.

研究的目的:

  • 开发新型重组腺相关病毒 (rAAV) 载体,提高眼科应用的疗效.
  • 通过修改它们的体来提高AAV载体的治疗指数.
  • 为了减少与眼部基因疗法相关的潜在炎症反应.

主要方法:

  • 使用生物结合化学来修改rAAV囊体.
  • 通过一种类尿素键,共性地将一个曼诺连接物与AAV囊氨基基组结合在一起.
  • 在老鼠和非人类灵长类动物视网膜中评估了载体转导效率.

主要成果:

  • 经过修改的rAAV向量显著提高了传导效率.
  • 通过氨酸键的曼诺配体合增强了视网膜组织中的载体性能.
  • 对AAV载体的优化显示了改善基因传递的潜力.

结论:

  • 开发了具有增强视网膜转导效率的新型rAAV载体.
  • 修改后的AAV囊提供了一种改善眼部基因疗法的治疗指数的策略.
  • 这些优化的载体对治疗各种视网膜疾病具有前途.